Form 4: Performant CFO Converts Equity in Merger Deal
Insider Transaction Report
Performant Healthcare Inc. Chief Financial Officer Rohit Ramchandani converted all his equity holdings into cash following the company's merger with Continental Buyer, Inc.
Summary
- Rohit Ramchandani, Chief Financial Officer of Performant Healthcare Inc. (PHLT), reported the conversion of all his beneficial ownership in company securities on October 21, 2025.
- This transaction was executed pursuant to the Agreement and Plan of Merger dated July 31, 2025, between Performant, Continental Buyer, Inc., and Prevail Merger Sub, Inc.
- Under the merger terms, Performant became a wholly-owned subsidiary of Continental Buyer, Inc.
- Each share of Performant's Common Stock was canceled and converted into the right to receive $7.75 in cash.
- Mr. Ramchandani disposed of 299,101 shares of Common Stock, resulting in zero beneficial ownership post-transaction.
- All outstanding restricted stock unit (RSU) awards, both time-based (257,067 units) and performance-based (189,366 units), were canceled in exchange for a lump sum cash payment equal to the number of underlying shares multiplied by the $7.75 Merger Consideration.
- Performance-based RSUs were deemed to have satisfied vesting conditions at 100% of target, with time-based conditions waived.
- 10,000 non-qualified stock options with an exercise price of $1.74 were also canceled, converting into a cash payment based on the difference between the $7.75 Merger Consideration and the exercise price.
- The total number of equity interests converted for Mr. Ramchandani was 755,534 units/shares (299,101 Common Stock + 257,067 time-based RSUs + 189,366 performance-based RSUs + 10,000 Stock Options).
- The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
Sentiment
Score: 7
Explanation: The sentiment is positive for former shareholders due to the cash consideration received in the merger, providing a definitive exit value. For the company, it represents a transition to private ownership, which is a neutral event in terms of public market sentiment but signifies a strategic change.
Positives
- The merger provided a clear cash exit for shareholders at a specified price of $7.75 per share, offering liquidity and certainty.
- The transaction for the Chief Financial Officer was conducted under a pre-arranged Rule 10b5-1 plan, indicating structured and compliant insider trading.
Negatives
- Performant Healthcare Inc. is no longer a publicly traded entity, meaning former shareholders will not participate in any future upside as a public company.
- The Chief Financial Officer, Rohit Ramchandani, no longer holds direct beneficial ownership in the company's public equity.
Future Outlook
Performant Healthcare Inc. is now a wholly-owned subsidiary of Continental Buyer, Inc., and its future outlook as an independent publicly traded entity is no longer applicable. Any future performance or strategic direction will be determined by its new parent company.
Industry Context
This merger reflects a trend of consolidation within the healthcare services sector, where companies are often acquired by larger entities or private equity firms seeking to integrate operations, achieve synergies, or take companies private for strategic restructuring. The acquisition of Performant by Continental Buyer, Inc. indicates a strategic move to integrate Performant's capabilities into a broader portfolio.
Stakeholder Impact
- Shareholders: Received $7.75 per share in cash for their holdings, providing a liquid exit from their investment.
- Employees (specifically the CFO): Equity awards were converted to cash, providing a payout for their vested and performance-accelerated interests.
- Company: Transitioned from a publicly traded entity to a wholly-owned subsidiary, implying changes in operational and strategic oversight under new ownership.
Key Dates
| Date | Description |
|---|---|
| 07/31/2025 | Date of the Agreement and Plan of Merger between Performant Healthcare, Inc., Continental Buyer, Inc., and Prevail Merger Sub, Inc. |
| 10/21/2025 | Date of Earliest Transaction, representing the effective time of the merger and conversion of securities. |
Keywords
Performant Healthcare, PHLT, Merger, Acquisition, Form 4, Insider Transaction, Rohit Ramchandani, Chief Financial Officer, Equity Conversion, Restricted Stock Units, Stock Options, Continental Buyer Inc., Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.